Ping Feng

Ping Feng has a diverse work experience spanning several companies and roles. In the present, they hold the position of Vice President at both Genekey Biotechnology and Salubris Biotherapeutics, starting in October 2018. Prior to that, Ping Feng was a Sr. Director at Teva Pharmaceuticals starting in April 2017. Their longest tenure was at Teva Biopharmaceuticals, USA, where they served as Director of Global Biological CMC starting in August 2007. Before that, they also worked as a Scientist at Teva Biopharmaceuticals from April 2005 to July 2007. Ping Feng began their career as a Scientist at Human Genome Sciences from April 2003 to March 2005. The earliest work experience listed is as a Visiting Fellow at the American Red Cross from 1989 to 1993.

Ping Feng completed a Master of Science degree in Molecular and Cell Biology at the Shanghai Institute of Cell Biology, Chinese Academy of Science from 1985 to 1988. There is no information available regarding Ping Feng's education prior to this, as the start year, end year, degree name, and field of study are not provided for the education at Sichuan University.